Particle-based artificial three-dimensional stem cell spheroids for revascularization of ischemic diseases

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Vascular Biology

Background:

• Developing biomimetic vasculature networks is crucial for regenerative medicine but remains challenging.
• Current stem cell therapies face delivery and efficacy limitations.

Purpose of the Study:

• To introduce a novel particle-based artificial stem cell spheroid (ASSP) technology.
• To recapitulate the paracrine functions of stem cell spheroids (SSPs) for enhanced vasculature regeneration.
• To evaluate the therapeutic potential of ASSPs in preclinical models of ischemic diseases.

Main Methods:

• Induction of stem cell aggregation into 3D spheroids utilizing a facile method.
• Enhancement of proangiogenic factor secretion through a hypoxia microenvironment.
• Artificial reconstruction of 3D spheroids (ASSPs) by integrating SSP-secreted factors into cell membrane-coated micro-/nanoparticles.
• Evaluation of ASSP efficacy in hindlimb ischemia and myocardial infarction models.

Main Results:

• ASSP technology effectively mimics paracrine functions of native SSPs.
• Hypoxia-driven enhancement of proangiogenic factors within 3D spheroids.
• Controllable particle sizes (micro- and nanoparticles) of ASSPs demonstrated superior revascularization effects.
• ASSP microparticles promoted local revascularization in hindlimb ischemia models.
• ASSP nanoparticles facilitated systemic delivery and therapeutic effects in myocardial infarction models.

Conclusions:

• ASSP technology presents a promising therapeutic strategy for ischemic tissue regeneration.
• This approach overcomes limitations in stem cell therapy delivery and development.
• ASSP technology offers a viable alternative for enhancing vascularization in regenerative medicine.